15 May 2002
Blood serum levels of soluble forms of adhesion molecules ICAM-1 (sICAM-1)and selectin E (s-selectin E) in patients with various phases of non-Hodgkin's lymphomas.
Dariusz Wołowiec, Irena Frydecka, Katarzyna Kapelko-Słowik, Stanisław Potoczek, Donata Urbaniak-Kujda, Kazimierz KuliczkowskiMed Sci Monit 2002; 8(5): BR175-178 :: ID: 420849
Abstract
BACKGROUND: Monitoring of disease activity and effectiveness of treatmentplays an important role in curative management of patients with non-Hodgkin's lymphomas (n-HL). In thesearch for markers useful for biochemical monitoring of n-HL patients, a group of proteins called adhesionmolecules attracted attention. Particular attention has been devoted to sICAM-1 (intercellular adhesionmolecule-1). A correlation between sICAM-1 levels and histological malignancy grades and clinical stagingof n-HL, activity of the disease and tumor mass has been observed. The aim of the study was to assessthe utility of determining serum levels of selected adhesion molecules in n-HL monitoring. The studywas carried out in 60 patients with intermediate and high malignancy grade n-HL according to WorkingFormulation (anaplastic, lymphoblastic, immunoblastic, centroblastic and centroblastic-centrocytic).MATERIAL/METHODS: Soluble ICAM-1 adhesion molecule (sICAM-1) and selectin E levels were determined inthe sera of 31 newly diagnosed patients, 18 with complete remission, and 11 with relapse of the disease.The control group consisted of 15 healthy subjects. The results were expressed in ng/ml. RESULTS: sICAM1levels were similar in healthy controls and patients in the remission phase and significantly lower inpatients with diagnosed active disease and relapses. Relapses were associated with slightly lower levels(on borderline of statistical significance) than of diagnosis Serum selectin E levels, however, demonstratedno differences among patient groups or as compared with controls. CONCLUSIONS: The presented resultsindicate the utility of serum sICAM-1 level determination in assessment of activity of intermediate andhigh malignancy grade non-Hodgkin's lymphomas.
Keywords: Adolescent, Case-Control Studies, Cell Adhesion, E-Selectin, Intercellular Adhesion Molecule-1, Lymphoma, Non-Hodgkin
Editorial
01 November 2024 : Editorial
Editorial: Artificial Intelligence (AI), Digital Image Analysis, and the Future of Cancer Diagnosis and PrognosisDOI: 10.12659/MSM.947038
Med Sci Monit 2024; 30:e947038
In Press
Review article
Comprehensive Insights into Arecoline Hydrobromide: Pharmacology, Toxicity, and PharmacokineticsMed Sci Monit In Press; DOI: 10.12659/MSM.945582
Clinical Research
Iliac Periosteal Bone Autografting vs Talus Non-Weight-Bearing Surgery in Hepple V Talus Osteochondral Inju...Med Sci Monit In Press; DOI: 10.12659/MSM.944912
Clinical Research
Impact of Different Orthodontic Appliances on Mandibular Condyle, Anterior Region of Mandibular, and Maxill...Med Sci Monit In Press; DOI: 10.12659/MSM.946265
Clinical Research
Risk Factors for Bone Cement Displacement After Percutaneous Kyphoplasty in Osteoporotic Vertebral Fracture...Med Sci Monit In Press; DOI: 10.12659/MSM.945884
Most Viewed Current Articles
17 Jan 2024 : Review article 6,371,831
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,909,013
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 695,468
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 260,595
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074